Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 4.005 USD 1.39% Market Closed
Market Cap: 183.6m USD
Have any thoughts about
Repro Med Systems Inc?
Write Note

Net Margin
Repro Med Systems Inc

-48.2%
Current
-25%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-48.2%
=
Net Income
-13.7m
/
Revenue
28.5m

Net Margin Across Competitors

Country US
Market Cap 182.9m USD
Net Margin
-48%
Country US
Market Cap 199B USD
Net Margin
14%
Country US
Market Cap 191.3B USD
Net Margin
29%
Country US
Market Cap 141.3B USD
Net Margin
16%
Country US
Market Cap 134.2B USD
Net Margin
11%
Country IE
Market Cap 104.6B USD
Net Margin
13%
Country US
Market Cap 65.6B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.5B USD
Net Margin
74%
Country CN
Market Cap 310B CNY
Net Margin
33%
Country US
Market Cap 36.3B USD
Net Margin
9%
No Stocks Found

Repro Med Systems Inc
Glance View

Market Cap
182.9m USD
Industry
Health Care

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

KRMD Intrinsic Value
3.136 USD
Overvaluation 22%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-48.2%
=
Net Income
-13.7m
/
Revenue
28.5m
What is the Net Margin of Repro Med Systems Inc?

Based on Repro Med Systems Inc's most recent financial statements, the company has Net Margin of -48.2%.